raw materials – Page 3

Potential nitrosamine source identified during regulatory inspection – FDA/EMA nitrosamine expectations

Identifying Sources of Nitrosamines During Regulatory Inspections: A Comprehensive Playbook The pharmaceutical industry faces stringent scrutiny regarding the presence of nitrosamines in raw materials. Instances where a potential nitrosamine source…

Storage condition excursion during warehouse operations – inspection defense documentation

Analysis and Documentation of Storage Condition Excursions in Warehouse Operations In pharmaceutical manufacturing, maintaining stringent storage conditions during warehouse operations is crucial for product integrity and compliance with regulatory standards.…

Regulatory query on nitrosamines during regulatory inspection – CAPA for nitrosamine findings

Playbook for Managing Nitrosamine Regulatory Queries During Inspections Regulatory queries regarding nitrosamines have become increasingly common during inspections by agencies such as the FDA, EMA, and MHRA. These queries often…

Storage condition excursion during routine checks – inspection defense documentation

Addressing Storage Condition Excursions During Routine Checks in Pharmaceutical Manufacturing Storage condition excursions during routine checks can lead to significant quality concerns in pharmaceutical manufacturing. These deviations not only pose…

Nitrosamine risk assessment incomplete during submission support – inspection-ready justification

Nitrosamine Risk Assessment: Completing the Submission Support Justification Pharmaceutical professionals face increasing scrutiny regarding nitrosamine risks associated with raw materials and excipients. Incomplete risk assessments during submission phases can lead…

Improper segregation of materials during routine checks – CAPA for warehouse failures

Addressing Material Mismanagement during Routine Checks in Warehousing Improper segregation of materials during routine checks can lead to significant risks in pharmaceutical manufacturing, impacting product quality, compliance, and patient safety.…

Potential nitrosamine source identified during risk assessment – CAPA for nitrosamine findings

Identifying Potential Nitrosamine Sources: An Actionable CAPA Playbook Nitrosamine contamination has emerged as a significant concern in pharmaceutical manufacturing, particularly with raw materials and excipients. These impurities can pose risks…

FIFO not followed during warehouse operations – product quality impact assessment

Assessing the Impact of Non-Adherence to FIFO Principles in Pharmaceutical Warehousing In pharmaceutical manufacturing, adherence to proper material storage protocols is critical to ensure product quality and compliance with Good…

Nitrosamine risk assessment incomplete during submission support – CAPA for nitrosamine findings

Addressing Incomplete Nitrosamine Risk Assessments During Regulatory Submissions The pharmaceutical industry faces increasing scrutiny regarding nitrosamine contamination in products, particularly in the context of regulatory submissions. When nitrosamines are detected…

Storage condition excursion during inspection walkthrough – product quality impact assessment

Assessing Product Quality Impact from Storage Condition Excursions during Walkthrough Inspections Storage condition excursions can pose significant challenges in pharmaceutical manufacturing, particularly during inspection walkthroughs. These deviations may lead to…

Nitrosamine risk assessment incomplete during submission support – risk mitigation and control strategy

Mitigating Incomplete Nitrosamine Risk Assessments During Submission Support Nitrosamines are a significant concern in pharmaceutical manufacturing, especially regarding regulatory submission support. Incomplete risk assessments related to nitrosamines can lead to…

FIFO not followed during inventory reconciliation – CAPA for warehouse failures

Addressing FIFO Non-compliance in Inventory Reconciliation: A Comprehensive Investigation In the realm of pharmaceutical manufacturing, inventory management is critical to ensuring product integrity, compliance, and patient safety. A common scenario…